JNBA Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $541K | Buy |
4,283
+30
| +0.7% | +$3.95K | 0.04% | 138 |
|
|
2026
Q1 | $593K | Sell |
4,253
-20
| -0.5% | -$2.8K | 0.05% | 134 |
|
|
2025
Q4 | $524K | Sell |
4,273
-147
| -3% | -$17.9K | 0.05% | 139 |
|
|
2025
Q3 | $491K | Hold |
4,420
| – | – | 0.04% | 136 |
|
|
2025
Q2 | $490K | Hold |
4,420
| – | – | 0.05% | 135 |
|
|
2025
Q1 | $495K | Sell |
4,420
-20
| -0.5% | -$2.06K | 0.05% | 130 |
|
|
2024
Q4 | $410K | Sell |
4,440
-44
| -1% | -$3.96K | 0.04% | 142 |
|
|
2024
Q3 | $376K | Sell |
4,484
-100
| -2% | -$7.63K | 0.04% | 144 |
|
|
2024
Q2 | $315K | Hold |
4,584
| – | – | 0.03% | 156 |
|
|
2024
Q1 | $336K | Buy |
4,584
+95
| +2% | +$7.3K | 0.04% | 161 |
|
|
2023
Q4 | $364K | Buy |
4,489
+100
| +2% | +$7.78K | 0.04% | 156 |
|
|
2023
Q3 | $329K | Buy |
4,389
+5
| +0.1% | +$385 | 0.04% | 157 |
|
|
2023
Q2 | $338K | Sell |
4,384
-56
| -1% | -$4.47K | 0.04% | 159 |
|
|
2023
Q1 | $368K | Sell |
4,440
-92
| -2% | -$7.62K | 0.05% | 149 |
|
|
2022
Q4 | $389K | Sell |
4,532
-1,160
| -20% | -$91.9K | 0.05% | 143 |
|
|
2022
Q3 | $351K | Sell |
5,692
-300
| -5% | -$18.9K | 0.05% | 147 |
|
|
2022
Q2 | $370K | Sell |
5,992
-100
| -2% | -$6.19K | 0.06% | 136 |
|
|
2022
Q1 | $362K | Sell |
6,092
-400
| -6% | -$25.6K | 0.05% | 145 |
|
|
2021
Q4 | $471K | Sell |
6,492
-26
| -0.4% | -$1.79K | 0.06% | 134 |
|
|
2021
Q3 | $455K | Hold |
6,518
| – | – | 0.06% | 132 |
|
|
2021
Q2 | $449K | Sell |
6,518
-500
| -7% | -$33.4K | 0.06% | 130 |
|
|
2021
Q1 | $454K | Sell |
7,018
-1
| -0% | -$64 | 0.07% | 122 |
|
|
2020
Q4 | $409K | Sell |
7,019
-199
| -3% | -$12K | 0.07% | 123 |
|
|
2020
Q3 | $456K | Hold |
7,218
| – | – | 0.09% | 98 |
|
|
2020
Q2 | $555K | Sell |
7,218
-30
| -0.4% | -$2.3K | 0.12% | 92 |
|
|
2020
Q1 | $542K | Buy |
7,248
+600
| +9% | +$41.5K | 0.13% | 86 |
|
|
2019
Q4 | $432K | Buy |
6,648
+126
| +2% | +$8.21K | 0.08% | 105 |
|
|
2019
Q3 | $413K | Buy |
6,522
+365
| +6% | +$23.9K | 0.08% | 102 |
|
|
2019
Q2 | $416K | Buy |
6,157
+200
| +3% | +$13.2K | 0.08% | 104 |
|
|
2019
Q1 | $387K | Hold |
5,957
| – | – | 0.08% | 104 |
|
|
2018
Q4 | $373K | Sell |
5,957
-42,648
| -88% | -$2.98M | 0.08% | 100 |
|
|
2018
Q3 | $3.75M | Buy |
48,605
+41,398
| +574% | +$3.13M | 1.68% | 24 |
|
|
2018
Q2 | $511K | Sell |
7,207
-600
| -8% | -$42.4K | 0.11% | 86 |
|
|
2018
Q1 | $589K | Hold |
7,807
| – | – | 0.13% | 78 |
|
|
2017
Q4 | $559K | Sell |
7,807
-525
| -6% | -$39.9K | 0.12% | 78 |
|
|
2017
Q3 | $675K | Hold |
8,332
| – | – | 0.15% | 64 |
|
|
2017
Q2 | $590K | Sell |
8,332
-500
| -6% | -$33.3K | 0.13% | 67 |
|
|
2017
Q1 | $600K | Buy |
8,832
+190
| +2% | +$13.4K | 0.14% | 66 |
|
|
2016
Q4 | $619K | Buy |
8,642
+4,087
| +90% | +$304K | 0.15% | 64 |
|
|
2016
Q3 | $360K | Sell |
4,555
-2,645
| -37% | -$215K | 0.05% | 132 |
|
|
2016
Q2 | $601K | Buy |
7,200
+725
| +11% | +$64.3K | 0.17% | 56 |
|
|
2016
Q1 | $595K | Sell |
6,475
-100
| -2% | -$9.02K | 0.21% | 55 |
|
|
2015
Q4 | $665K | Sell |
6,575
-350
| -5% | -$36.4K | 0.25% | 45 |
|
|
2015
Q3 | $680K | Sell |
6,925
-375
| -5% | -$41.6K | 0.29% | 39 |
|
|
2015
Q2 | $855K | Sell |
7,300
-450
| -6% | -$49.2K | 0.32% | 35 |
|
|
2015
Q1 | $761K | Buy |
7,750
+400
| +5% | +$40.6K | 0.29% | 40 |
|
|
2014
Q4 | $693K | Buy |
7,350
+2,610
| +55% | +$270K | 0.28% | 43 |
|
|
2014
Q3 | $505K | Sell |
4,740
-25
| -0.5% | -$2.45K | 0.23% | 51 |
|
|
2014
Q2 | $395K | Buy |
4,765
+2,275
| +91% | +$177K | 0.19% | 60 |
|
|
2014
Q1 | $176K | Buy |
2,490
+450
| +22% | +$35.3K | 0.09% | 95 |
|
|
2013
Q4 | $153K | Sell |
2,040
-230
| -10% | -$16K | 0.08% | 95 |
|
|
2013
Q3 | $143K | Sell |
2,270
-114
| -5% | -$6.81K | 0.09% | 94 |
|
|
2013
Q2 | $122K | Buy |
+2,384
| New | +$124K | 0.08% | 102 |
|
Other funds holding GILD
CIM
ATO
CGH
JNBA Financial Advisors's GILD Position: Q2 2026 in Review
JNBA Financial Advisors increased its Gilead Sciences (GILD) stake by 0.71% in Q2 2026, buying an estimated $3.95K and bringing the position to 4,283 shares worth $541K. The position accounts for 0.04% of the portfolio, ranked #138.
JNBA Financial Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.75M in Q3 2018. 758 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- JNBA Financial Advisors held 4,283 shares of Gilead Sciences worth $541K as of Q2 2026.
- JNBA Financial Advisors bought 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
- Gilead Sciences made up 0.04% of JNBA Financial Advisors's portfolio in Q2 2026, its #138 holding.
- JNBA Financial Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- JNBA Financial Advisors's Gilead Sciences position peaked at $3.75M in Q3 2018.
- 758 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.